SEC Form 4 · accession 0001127602-19-008330
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Officer — Chairman, President and CEO · Director
Period of report
Feb 25, 2019
Accepted (ET)
Feb 26, 2019 · 3:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 25, 2019 | M | 24,008 | $88.05 | A | 307,652 | D | |
| Common Stock | Feb 25, 2019 | M | 20,295 | $109.34 | A | 327,947 | D | |
| Common Stock | Feb 25, 2019 | S | 200 | $144.11 | D | 327,747 | D | |
| Common Stock | Feb 25, 2019 | S | 300 | $144.115 | D | 327,447 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $144.145 | D | 327,347 | D | |
| Common Stock | Feb 25, 2019 | S | 400 | $144.16 | D | 326,947 | D | |
| Common Stock | Feb 25, 2019 | S | 300 | $144.18 | D | 326,647 | D | |
| Common Stock | Feb 25, 2019 | S | 200 | $144.28 | D | 326,447 | D | |
| Common Stock | Feb 25, 2019 | S | 46 | $144.285 | D | 326,401 | D | |
| Common Stock | Feb 25, 2019 | S | 400 | $144.31 | D | 326,001 | D | |
| Common Stock | Feb 25, 2019 | S | 400 | $144.32 | D | 325,601 | D | |
| Common Stock | Feb 25, 2019 | S | 200 | $144.33 | D | 325,401 | D | |
| Common Stock | Feb 25, 2019 | S | 600 | $144.35 | D | 324,801 | D | |
| Common Stock | Feb 25, 2019 | S | 500 | $144.36 | D | 324,301 | D | |
| Common Stock | Feb 25, 2019 | S | 142 | $144.365 | D | 324,159 | D | |
| Common Stock | Feb 25, 2019 | S | 509 | $144.37 | D | 323,650 | D | |
| Common Stock | Feb 25, 2019 | S | 300 | $144.375 | D | 323,350 | D | |
| Common Stock | Feb 25, 2019 | S | 12 | $144.385 | D | 323,338 | D | |
| Common Stock | Feb 25, 2019 | S | 300 | $144.39 | D | 323,038 | D | |
| Common Stock | Feb 25, 2019 | S | 210 | $144.40 | D | 322,828 | D | |
| Common Stock | Feb 25, 2019 | S | 156 | $144.405 | D | 322,672 | D | |
| Common Stock | Feb 25, 2019 | S | 1,000 | $144.42 | D | 321,672 | D | |
| Common Stock | Feb 25, 2019 | S | 20 | $144.425 | D | 321,652 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $88.05 | Feb 25, 2019 | M | 24,008 | D | Feb 24, 2018 | Feb 24, 2022 | Common Stock | 24,008 | 48,017 | D |
| Stock Options (Right to Buy) | $109.34 | Feb 25, 2019 | M | 20,295 | D | Feb 23, 2019 | Feb 23, 2023 | Common Stock | 20,295 | 60,886 | D |
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.